Fingerprint
Dive into the research topics of 'Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically